Clinical Trials Logo

Clinical Trial Summary

This study is being done to assess the feasibility of administrating Δ9-THC and Δ8-THC isolates and simultaneously adopting several data harmonization measures to generate uniquely translatable data. This project aims to (1) evaluate the feasibility and acceptability of administering ∆9-THC and Δ8-THC isolates using standardized cannabis dosing units to quantify ∆9-THC and Δ8-THC pharmacokinetics; and (2) evaluate the feasibility and acceptability of adopting standardized impairment detection methods and driving performance definitions and measures on quantifying ∆9-THC and Δ8-THC driving impairment compared to a placebo.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06236815
Study type Interventional
Source University of Wisconsin, Madison
Contact Heather Barkholtz, PhD
Phone 608-890-1967
Email hbarkholtz@wisc.edu
Status Not yet recruiting
Phase Early Phase 1
Start date June 2024
Completion date January 2025

See also
  Status Clinical Trial Phase
Completed NCT05187117 - CAPABLE Family Pilot - Adapting CAPABLE for Older Adults With Mild Cognitive Impairment (MCI)/Early Stage Dementia and Their Care Partners N/A
Recruiting NCT04819529 - Early and Intensive Occupational Therapy in Mechanical Ventilated Patients N/A
Recruiting NCT04904497 - Early Occupational Therapy in Mechanical Ventilated Patients With Covid-19 N/A